Inhibition of SRC-3 enhances sensitivity of human cancer cells to histone deacetylase inhibitors.

导出 LinkOut

翻译打印收藏纠错

第一作者： Zhengzhi,Zou

第一单位： MOE Key Laboratory of Laser Life Science and Institute of Laser Life Science, College of Biophotonics, South China Normal University, Guangzhou 510000, China. Electronic address: zouzhengzhi@m.scnu.edu.cn.

作者： Zhengzhi,Zou ^[1] ; Xiaoyong,Luo ^[2] ; Peipei,Nie ^[3] ; Baoyan,Wu ^[4] ; Tao,Zhang ^[4] ; Yanchun,Wei ^[4] ; Wenyi,Wang ^[5] ; Guojun,Geng ^[6] ; Jie,Jiang ^[6] ; Yanjun,Mi ^[7]

作者单位： MOE Key Laboratory of Laser Life Science and Institute of Laser Life Science, College of Biophotonics, South China Normal University, Guangzhou 510000, China. Electronic address: zouzhengzhi@m.scnu.edu.cn. ^[1] Department of Oncology, The Affiliated Luoyang Central Hospital of Zhengzhou University, Luoyang 471000, China. ^[2] KingMed Diagnostics and KingMed School of Laboratory Medicine, Guangzhou Medical University, Guangzhou 510000, China. ^[3] MOE Key Laboratory of Laser Life Science and Institute of Laser Life Science, College of Biophotonics, South China Normal University, Guangzhou 510000, China. ^[4] Xiamen Cancer Center, Department of Medical Oncology, The First Affiliated Hospital of Xiamen University, Xiamen 361000, China. ^[5] Xiamen Cancer Center, Department of Thoracic Surgery, The First Affiliated Hospital of Xiamen University, Xiamen 361000, China. ^[6] Xiamen Cancer Center, Department of Medical Oncology, The First Affiliated Hospital of Xiamen University, Xiamen 361000, China. Electronic address: myjgj_77@163.com. ^[7]

关键词 AKT Apoptosis Bcl-2 Cancer HDAC SRC-3